Twist Bioscience Corp. (TWST)
188.67
+0.62
(+0.33%)
USD |
NASDAQ |
Oct 02, 16:00
189.79
+1.12
(+0.59%)
After-Hours: 20:00
Twist Bioscience Profit Margin (Quarterly) : -29.61% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -29.61% |
| March 31, 2026 | -39.76% |
| December 31, 2025 | -29.42% |
| September 30, 2025 | -27.41% |
| June 30, 2025 | 21.23% |
| March 31, 2025 | -42.38% |
| December 31, 2024 | -35.61% |
| September 30, 2024 | -40.91% |
| June 30, 2024 | -105.0% |
| March 31, 2024 | -60.41% |
| December 31, 2023 | -60.15% |
| September 30, 2023 | -69.08% |
| June 30, 2023 | -90.05% |
| March 31, 2023 | -98.30% |
| December 31, 2022 | -77.10% |
| September 30, 2022 | -89.20% |
| June 30, 2022 | -107.8% |
| March 31, 2022 | -126.1% |
| December 31, 2021 | -108.4% |
| September 30, 2021 | -108.7% |
| Date | Value |
|---|---|
| June 30, 2021 | -114.3% |
| March 31, 2021 | -121.5% |
| December 31, 2020 | -116.8% |
| September 30, 2020 | -74.98% |
| June 30, 2020 | -133.0% |
| March 31, 2020 | -164.6% |
| December 31, 2019 | -324.2% |
| September 30, 2019 | -198.2% |
| June 30, 2019 | -205.3% |
| March 31, 2019 | -191.3% |
| December 31, 2018 | -197.0% |
| September 30, 2018 | -235.5% |
| June 30, 2018 | -269.4% |
| March 31, 2018 | -273.6% |
| December 31, 2017 | -392.7% |
| September 30, 2017 | -490.7% |
| June 30, 2017 | -450.8% |
| March 31, 2017 | -593.8% |
| December 31, 2016 | -800.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -25.04K% |
| Intellia Therapeutics, Inc. | -1.39K% |
| Prime Medicine, Inc. | -3.65K% |
| Absci Corp. | -10.44K% |
| 10X Genomics, Inc. | -11.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.62% |
| Return on Assets | -20.89% |
| Return on Invested Capital | -24.86% |
| Gross Profit Margin (Quarterly) | 52.76% |
| Operating Margin (Quarterly) | -30.65% |
| Return on Net Operating Assets | -38.83% |